Company News »

CEREC Meets Invisalign(R): Sirona Expands Its Orthodontic Product Line to Include Invisalign Digital Impression Submission

Business Wire
Share on StockTwits
Published on

Sirona (NASDAQ:SIRO) , the dental technology leader, today announced that the Company’s CEREC Omnicam and new CEREC Ortho Software can be used to submit digital impressions for Invisalign(R) clear aligner therapy. This new cooperation brings together the market leader in clear aligner therapy and the market leader in dental CAD/CAM.

The new Ortho 1.1 software features a patent-pending guided scanning process and connects the CEREC world with Invisalign treatment by allowing seamless digital impression submission. The new software, exclusive for CEREC Omnicam systems, will be available in selected markets by summer 2015.

Jeffrey T. Slovin, President and Chief Executive Officer of Sirona commented: “We are delighted to be able to offer Invisalign digital impression submission to our family of orthodontic applications for our Omnicam users and the dental community. For over 30 years, Sirona has been leading dentistry into a digital era, and this expanded offering will help expedite the adoption of technology by general practitioners and orthodontists, a new market segment for us.”

Mr. Slovin continued: “Through expanded offerings such as this one, we are bolstering our strategy to deliver best-in-class products and customer support for dental professionals. We believe that this strategy combined with our continuous innovation will drive penetration of digital dentistry and will deliver increasing shareholder value.”

About Sirona Dental Systems, Inc.

Sirona, the dental technology leader, has served dealers and dentists worldwide for more than 130 years. Sirona develops, manufactures, and markets a complete line of dental products, including CADCAM restoration systems (CEREC), digital intra-oral, panoramic and 3D imaging systems, dental treatment centers and handpieces. Visit for more information about Sirona and its products.

Share on StockTwits